Head-to-head · Cost-Efficiency Index
Welling Health vs Pallas Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Welling Health
Patients willing to log meals daily in exchange for a lower effective GLP-1 price.
Visit Welling HealthPallas Health
Shoppers comfortable paying a quarter at a time who want the whole cost stated before signup, and who are not looking for a month-to-month exit.
Visit Pallas HealthThe verdict
Welling Health takes it, leading the Cost-Efficiency Index 78 to 74. Welling Health is a clinician-led metabolic telehealth platform charging a flat $190/month for compounded semaglutide and $275/month for compounded tirzepatide, all doses, with no setup or consultation fees. Pallas Health still earns a C — Shoppers comfortable paying a quarter at a time who want the whole cost stated before signup, and who are not looking for a month-to-month exit.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Welling Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Welling Health | Pallas Health |
|---|---|---|
| Cost-Efficiency Index | 78/100 | 74/100 |
| Semaglutide / mo | $190/mo (all doses, promotional rate, compounded) | $199/mo average — Pallas's own figure for $597 billed every 12 weeks, its only cadence; $139 covers the first 4 weeks |
| Tirzepatide / mo | $275/mo (all doses, compounded) | $299/mo average — Pallas's own figure for $897 billed every 12 weeks, its only cadence; $179 covers the first 4 weeks |
| Semaglutide / yr (modeled) | $2,280 | $2,388 |
| Tirzepatide / yr (modeled) | $3,300 | $3,588 |
| Coverage | All 50 states | Most states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #37 | #42 |
Welling Health
78/100Where the value is
- Flat, dose-independent base pricing with no setup or consultation fees disclosed
- Licensed in all 50 states
- Named pharmacy tier (LegitScript-certified 503A, USP <797>) even though the specific pharmacy isn't named
The tradeoffs
- The eye-catching ~30%-off streak price is not the standing rate — it requires 30 unbroken consecutive days of in-app meal logging and resets if a day is missed, so $190/$275 is the realistic price for most patients most of the time
- Tirzepatide's $275 base rate is on the higher end of compounded competitors in this batch
Pallas Health
74/100Where the value is
- Both molecules are priced publicly, with the charged block stated rather than only a monthly average
- A genuinely reduced first cycle — $139 semaglutide and $179 tirzepatide for the first four weeks
- Runs a Spanish-language lander as well as the English site, which most of this field does not
The tradeoffs
- There is no monthly rung. The only cadence is a 12-week block paid up front — $597 or $897 — so the advertised 'per month' figure is arithmetic rather than a payment anyone makes
- A 12-week cycle is 4.33 charges a year, not 4, so a year costs more than four times the block
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.